# Calculation results of IVW methods

  


| exposure | nsnp | b | se | pval |
| :--- | :--- | :--- | :--- | :--- |
| 1,5-anhydroglucitol \(1,5-AG\) \|\| id:419 | 3 | -0.363916981 | 0.424453278 | 0.391235911 |
| 10-undecenoate \(11:1n1\) \|\| id:482 | 2 | -0.522563126 | 0.346868304 | 0.13193441 |
| 18:2, linoleic acid \(LA\) \|\| id:893 | 10 | 0.473982148 | 0.327713579 | 0.148084523 |
| 1-arachidonoylglycerophosphocholine\* \|\| id:558 | 3 | 0.134844664 | 0.278753565 | 0.628569346 |
| 1-arachidonoylglycerophosphoethanolamine\* \|\| id:682 | 2 | -0.296538752 | 1.096969547 | 0.786909912 |
| 1-arachidonoylglycerophosphoinositol\* \|\| id:634 | 2 | 0.270691888 | 0.432140523 | 0.53105403 |
| 1-eicosatrienoylglycerophosphocholine\* \|\| id:602 | 2 | -0.629025322 | 0.455757914 | 0.16753301 |
| 1-linoleoylglycerophosphoethanolamine\* \|\| id:497 | 2 | -0.300314682 | 0.341215891 | 0.378788349 |
| 1-palmitoylglycerophosphoethanolamine \|\| id:707 | 2 | -0.798595905 | 0.992988312 | 0.421261298 |
| 22:6, docosahexaenoic acid \|\| id:852 | 4 | 0.017157071 | 0.100498138 | 0.864443712 |
| 2-aminobutyrate \|\| id:471 | 2 | 0.211768403 | 0.771221232 | 0.78363248 |
| 2hr glucose \|\| id:776 | 7 | 0.116772569 | 0.07939389 | 0.141345091 |
| 2-hydroxyisobutyrate \|\| id:427 | 3 | -0.559630799 | 0.506720716 | 0.269412439 |
| 3-dehydrocarnitine\* \|\| id:500 | 3 | -0.715620605 | 0.489131534 | 0.143455535 |
| 3-methyl-2-oxovalerate \|\| id:383 | 3 | 0.36784908 | 0.825955937 | 0.656058438 |
| 4-acetamidobutanoate \|\| id:339 | 2 | 0.119222275 | 0.573717776 | 0.835380069 |
| 4-androsten-3beta,17beta-diol disulfate 1\* \|\| id:747 | 2 | -0.111050494 | 0.269447176 | 0.680235357 |
| 4-androsten-3beta,17beta-diol disulfate 2\* \|\| id:748 | 2 | 0.093011731 | 0.339602728 | 0.784173818 |
| 4-methyl-2-oxopentanoate \|\| id:429 | 2 | 0.77082513 | 0.911325112 | 0.397648193 |
| 5alpha-androstan-3beta,17beta-diol disulfate \|\| id:746 | 3 | -0.213073603 | 0.143590325 | 0.137835601 |
| Acetylcarnitine \|\| id:463 | 2 | -0.361676056 | 0.664442756 | 0.586214478 |
| Acetylphosphate \|\| id:378 | 2 | -0.865989121 | 1.376024055 | 0.529125471 |
| Adiponectin \|\| id:1 | 11 | -0.182645561 | 0.134259093 | 0.173704577 |
| ADpSGEGDFXAEGGGVR\* \|\| id:601 | 2 | 0.199673486 | 0.292658033 | 0.49506459 |
| ADSGEGDFXAEGGGVR\* \|\| id:539 | 2 | -0.01908531 | 0.165734689 | 0.908321638 |
| Alanine \|\| id:469 | 2 | -0.987516793 | 1.230723284 | 0.422328929 |
| Alanine \|\| id:840 | 5 | -0.045281281 | 0.217105082 | 0.834785106 |
| Albumin \|\| id:841 | 2 | 0.176027004 | 0.206999692 | 0.395117595 |
| Alpha-hydroxyisovalerate \|\| id:616 | 3 | -0.570312902 | 0.349458981 | 0.102681991 |
| Amyotrophic lateral sclerosis \|\| id:1085 | 5 | 0.315865621 | 0.294381301 | 0.283279522 |
| Amyotrophic lateral sclerosis \|\| id:1086 | 3 | 0.055945578 | 0.076437849 | 0.464223885 |
| Androsterone sulfate \|\| id:460 | 3 | -0.167654417 | 0.102864863 | 0.103132957 |
| Apolipoprotein A-I \|\| id:842 | 9 | -0.148936432 | 0.080365535 | 0.06384831 |
| Apolipoprotein B \|\| id:843 | 13 | 0.449540532 | 0.266731034 | 0.091917172 |
| Arachidonic acid \(20:4n6\) \|\| id:1141 | 56 | 0.002920382 | 0.002147511 | 0.173864166 |
| Asparagine \|\| id:638 | 2 | 0.115595736 | 0.571713012 | 0.83976671 |
| Asthma \|\| id:44 | 7 | 0.009688281 | 0.043815427 | 0.825002314 |
| Average number of double bonds in a fatty acid chain \|\| id:851 | 5 | 0.007472527 | 0.060375849 | 0.901499897 |
| Average number of methylene groups in a fatty acid chain \|\| id:848 | 3 | -0.185549977 | 0.440558257 | 0.673630856 |
| Average number of methylene groups per double bond \|\| id:847 | 5 | -0.113696791 | 0.230795416 | 0.622273908 |
| Betaine \|\| id:362 | 3 | -0.015268284 | 0.552341116 | 0.977947003 |
| Bipolar disorder \|\| id:800 | 4 | -0.015673649 | 0.058762728 | 0.789678801 |
| Bipolar disorder \|\| id:801 | 4 | -0.015673649 | 0.058762728 | 0.789678801 |
| Birth length \|\| id:29 | 2 | -0.221601646 | 0.291939746 | 0.44781285 |
| Birth weight \|\| id:1083 | 41 | -0.057557531 | 0.096500639 | 0.550876548 |
| Birth weight \|\| id:1084 | 48 | -0.144537809 | 0.101582015 | 0.154774394 |
| Birth weight \|\| id:27 | 4 | -0.110474436 | 0.231559328 | 0.633298661 |
| Body fat \|\| id:999 | 9 | -3.778876005 | 2.94195583 | 0.198974939 |
| Body mass index \|\| id:2 | 75 | -0.011364864 | 0.096246234 | 0.906003378 |
| Body mass index \|\| id:835 | 65 | 0.030136623 | 0.105992294 | 0.776158698 |
| Bradykinin, des-arg\(9\) \|\| id:656 | 3 | -0.081841744 | 0.074463927 | 0.271733575 |
| Butyrylcarnitine \|\| id:476 | 5 | 0.022637844 | 0.095558664 | 0.812734396 |
| Caprylate \(8:0\) \|\| id:481 | 2 | -1.451649277 | 1.168250956 | 0.21402138 |
| Carnitine \|\| id:379 | 16 | -0.496393213 | 0.741724959 | 0.50334136 |
| Celiac disease \|\| id:1058 | 11 | -0.015910284 | 0.019698182 | 0.419261476 |
| Celiac disease \|\| id:1059 | 11 | -0.037722498 | 0.024695283 | 0.126632161 |
| Celiac disease \|\| id:1060 | 7 | -0.015241933 | 0.030594859 | 0.618352891 |
| Celiac disease \|\| id:276 | 12 | -0.030398621 | 0.023744945 | 0.200469727 |
| Childhood obesity \|\| id:1096 | 5 | -0.046724284 | 0.044763713 | 0.296578756 |
| Cholesterol \|\| id:307 | 2 | -0.471383049 | 1.026603533 | 0.646113837 |
| Cholesterol esters in large HDL \|\| id:875 | 9 | -0.465404607 | 0.822731728 | 0.57160991 |
| Cholesterol esters in large VLDL \|\| id:881 | 17 | 0.18447513 | 0.128279875 | 0.15041488 |
| Cholesterol esters in large VLDL \|\| id:887 | 8 | 0.835980474 | 1.022031075 | 0.413380064 |
| Chronic kidney disease \|\| id:1102 | 4 | 0.027982904 | 0.062122103 | 0.65238597 |
| Chronotype \|\| id:1087 | 8 | 0.156926926 | 0.356880924 | 0.660141445 |
| Cis-4-decenoyl carnitine \|\| id:753 | 2 | 0.285439172 | 0.264566009 | 0.280634155 |
| cis-trans-18:2 \|\| id:1150 | 2 | -2.011286554 | 2.576281994 | 0.434982797 |
| Citrate \|\| id:341 | 6 | -1.155588186 | 0.580810157 | 0.046633441 |
| Citrate \|\| id:849 | 4 | -0.188724708 | 0.097030547 | 0.051774614 |
| Citrulline \|\| id:356 | 3 | 1.357489816 | 0.993770423 | 0.171939147 |
| College completion \|\| id:836 | 3 | -0.166122672 | 0.166616001 | 0.318745517 |
| Concentration of IDL particles \|\| id:870 | 13 | 0.146614323 | 0.161611104 | 0.364298655 |
| Concentration of large HDL particles \|\| id:878 | 7 | -0.361632395 | 0.890156705 | 0.684553774 |
| Concentration of large LDL particles \|\| id:884 | 17 | 0.181269946 | 0.130534771 | 0.164932595 |
| Concentration of large VLDL particles \|\| id:890 | 8 | 0.490305266 | 0.509336946 | 0.335731027 |
| Copper \|\| id:1073 | 2 | -0.144584218 | 0.072598111 | 0.04641826 |
| Coronary heart disease \|\| id:6 | 3 | 0.054657325 | 0.059149103 | 0.355455041 |
| Coronary heart disease \|\| id:7 | 37 | 0.09759381 | 0.259619659 | 0.706983278 |
| Coronary heart disease \|\| id:8 | 13 | -0.02249775 | 0.042466186 | 0.596264249 |
| Corrected insulin response \|\| id:761 | 2 | 0.057318233 | 0.093506058 | 0.539883272 |
| C-reactive protein \|\| id:1015 | 3 | 0.244753443 | 0.107812241 | 0.023196524 |
| Creatinine \|\| id:850 | 5 | -0.098890872 | 0.181410846 | 0.585670263 |
| Crohn's disease \|\| id:10 | 98 | -0.028534491 | 0.016115088 | 0.076615727 |
| Crohn's disease \|\| id:11 | 9 | -0.015011572 | 0.015350144 | 0.328102332 |
| Crohn's disease \|\| id:12 | 109 | -0.028397255 | 0.017103721 | 0.096854737 |
| Crohn's disease \|\| id:30 | 45 | -0.018439348 | 0.0174674 | 0.291131105 |
| Decanoylcarnitine \|\| id:618 | 3 | 0.279918061 | 0.213495441 | 0.189817354 |
| Dehydroisoandrosterone sulfate \(DHEA-S\) \|\| id:478 | 2 | -0.614087946 | 0.443886574 | 0.166531716 |
| Dihomo-gamma-linolenic acid \(20:3n6\) \|\| id:1140 | 66 | 0.004896307 | 0.004199637 | 0.243659638 |
| Dihomo-linolenate \(20:3n3 or n6\) \|\| id:712 | 2 | -0.701365033 | 0.542839221 | 0.196346453 |
| Docosapentaenoic acid \(22:5n3\) \|\| id:1144 | 3 | 0.072327777 | 0.187915957 | 0.700315745 |
| Eicosapentaenoic acid \(20:5n3\) \|\| id:1147 | 2 | 0.025574004 | 0.092292442 | 0.781705248 |
| Epiandrosterone sulfate \|\| id:627 | 2 | -0.410032612 | 0.201898025 | 0.042266188 |
| Erythronate\* \|\| id:578 | 3 | 0.154489818 | 1.608298463 | 0.923474565 |
| Extreme body mass index \|\| id:85 | 7 | 0.013600751 | 0.054005615 | 0.801165069 |
| Extreme height \|\| id:86 | 42 | -0.007283862 | 0.015233693 | 0.632549439 |
| Extreme waist-to-hip ratio \|\| id:87 | 2 | -0.082700785 | 0.059239956 | 0.162705312 |
| Fasting glucose \|\| id:757 | 9 | 0.413182734 | 0.210419428 | 0.049574763 |
| Fasting glucose \|\| id:773 | 19 | 0.232753575 | 0.196021481 | 0.235074569 |
| Fasting glucose \|\| id:777 | 32 | 0.252853265 | 0.15946786 | 0.112828616 |
| Fasting insulin \|\| id:774 | 4 | -0.923759343 | 1.407522 | 0.511629904 |
| Fasting insulin \|\| id:775 | 4 | 0.23379232 | 0.457595322 | 0.609410568 |
| Fasting insulin \|\| id:778 | 14 | 0.385894362 | 0.290355259 | 0.183834081 |
| Fasting insulin \|\| id:779 | 14 | 0.243871801 | 0.284192928 | 0.390825882 |
| Fasting proinsulin \|\| id:769 | 6 | 0.024244793 | 0.094744375 | 0.798030442 |
| Ferritin \|\| id:1050 | 4 | 0.027403643 | 0.176721368 | 0.876768539 |
| Free cholesterol \|\| id:858 | 8 | 0.274829023 | 0.175987177 | 0.118372274 |
| Free cholesterol in IDL \|\| id:868 | 14 | 0.158624464 | 0.153754823 | 0.302226048 |
| Free cholesterol in large HDL \|\| id:876 | 11 | -0.42802024 | 0.735532165 | 0.560621152 |
| Free cholesterol in large LDL \|\| id:882 | 14 | 0.194212929 | 0.144197029 | 0.178025956 |
| Free cholesterol in large VLDL \|\| id:888 | 9 | 0.740964329 | 1.075021746 | 0.490662685 |
| Free cholesterol to esterified cholesterol ratio \|\| id:853 | 8 | 0.377747924 | 0.146586899 | 0.009967477 |
| Gamma-glutamylglutamine \|\| id:359 | 3 | -1.428605853 | 0.655467912 | 0.029293012 |
| Gamma-glutamylphenylalanine \|\| id:572 | 2 | 0.526257986 | 1.41756144 | 0.710457482 |
| Gamma-glutamyltyrosine \|\| id:360 | 3 | 0.850439336 | 0.942393573 | 0.36683125 |
| Gamma-linolenic acid \(18:3n6\) \|\| id:1139 | 167 | 0.012621011 | 0.0263069 | 0.631397729 |
| Glucose \|\| id:859 | 3 | 0.099706078 | 0.103510706 | 0.335425032 |
| Glutamine \|\| id:860 | 5 | -0.192007767 | 0.07812681 | 0.013985232 |
| Glutaroyl carnitine \|\| id:699 | 7 | 0.07182023 | 0.254744203 | 0.777996594 |
| Glycoprotein acetyls \|\| id:863 | 6 | 0.08425792 | 0.107641863 | 0.433767108 |
| Glycoproteins \|\| id:862 | 10 | -0.036291351 | 0.034138311 | 0.287751051 |
| Gout \|\| id:1054 | 2 | 0.02325214 | 0.029949503 | 0.437525737 |
| Haemoglobin concentration \|\| id:270 | 15 | -0.176232821 | 0.101444385 | 0.082345553 |
| HbA1C \|\| id:758 | 11 | 0.239368399 | 0.159422057 | 0.133232479 |
| HDL cholesterol \|\| id:299 | 85 | -0.273582464 | 0.227666541 | 0.229487302 |
| HDL cholesterol \|\| id:780 | 40 | -0.08039576 | 0.103390741 | 0.436809881 |
| Heart rate \|\| id:1056 | 15 | 0.008341862 | 0.010612022 | 0.431822609 |
| Height \|\| id:1034 | 4 | -0.137319633 | 0.106810227 | 0.198568297 |
| Height \|\| id:89 | 321 | -0.115878195 | 0.037717592 | 0.002124456 |
| Heptanoate \(7:0\) \|\| id:349 | 2 | 0.370659572 | 1.106832751 | 0.737713278 |
| Hexadecanedioate \|\| id:711 | 2 | 0.227777348 | 0.20372243 | 0.26353414 |
| Hexanoylcarnitine \|\| id:467 | 3 | 0.120559426 | 0.323600291 | 0.709478475 |
| Hip circumference \|\| id:48 | 47 | -0.225407422 | 0.116394744 | 0.052797033 |
| Hip circumference \|\| id:49 | 52 | -0.182739834 | 0.106499567 | 0.086185115 |
| Hip circumference \|\| id:54 | 68 | -0.225326736 | 0.085593619 | 0.008475455 |
| Hip circumference \|\| id:55 | 68 | -0.213754307 | 0.087737736 | 0.014838905 |
| Hippocampus volume \|\| id:1045 | 2 | 0.000947155 | 0.00040489 | 0.019320529 |
| Histidine \|\| id:866 | 3 | 0.021383209 | 0.119771659 | 0.858304306 |
| HOMA-B \|\| id:770 | 2 | -0.516290489 | 0.375305793 | 0.168929132 |
| HWESASXX\* \|\| id:526 | 2 | 0.75867659 | 0.276537321 | 0.006079042 |
| Hydroxyisovaleroyl carnitine \|\| id:698 | 2 | -0.376456513 | 0.641374337 | 0.557235355 |
| Inflammatory bowel disease \|\| id:292 | 109 | -0.023164534 | 0.01980593 | 0.242171768 |
| Inflammatory bowel disease \|\| id:293 | 7 | 0.001075582 | 0.019479556 | 0.955966417 |
| Inflammatory bowel disease \|\| id:294 | 121 | -0.02239647 | 0.017953303 | 0.21221983 |
| Inflammatory bowel disease \|\| id:31 | 56 | -0.007741119 | 0.022657947 | 0.732613264 |
| Iron \|\| id:1049 | 3 | -0.032347745 | 0.058841429 | 0.582494714 |
| Isobutyrylcarnitine \|\| id:573 | 2 | -0.72382955 | 0.435562092 | 0.096547142 |
| Isovalerylcarnitine \|\| id:652 | 3 | -0.117920364 | 0.297528266 | 0.691859152 |
| Kynurenine \|\| id:375 | 3 | -0.028801259 | 0.990325108 | 0.976798689 |
| Laurate \(12:0\) \|\| id:350 | 2 | 2.103196355 | 1.154750101 | 0.068554689 |
| LDL cholesterol \|\| id:300 | 72 | 0.170160884 | 0.101757996 | 0.094482638 |
| LDL cholesterol \|\| id:781 | 36 | 0.36644429 | 0.148977031 | 0.013903893 |
| Leucine \|\| id:306 | 12 | 0.648163116 | 0.847079382 | 0.444167942 |
| Levulinate \(4-oxovalerate\) \|\| id:433 | 2 | -1.478223222 | 1.005332886 | 0.141458366 |
| Linoleic acid \(18:2n6\) \|\| id:1142 | 71 | -0.001742599 | 0.000831897 | 0.03619506 |
| Mean cell haemoglobin \|\| id:271 | 30 | 0.010479179 | 0.029757133 | 0.724720631 |
| Mean cell haemoglobin concentration \|\| id:272 | 13 | -0.040276727 | 0.396806263 | 0.919151774 |
| Mean cell volume \|\| id:273 | 38 | 0.001575108 | 0.011612044 | 0.892102455 |
| Mean diameter for HDL particles \|\| id:865 | 9 | -0.14987272 | 0.140479725 | 0.286033384 |
| Mean platelet volume \|\| id:1006 | 22 | 0.209658878 | 0.333698535 | 0.529815109 |
| Multiple sclerosis \|\| id:1024 | 22 | -0.031580988 | 0.028735918 | 0.271764806 |
| Multiple sclerosis \|\| id:1025 | 37 | -0.022936363 | 0.023860235 | 0.33641148 |
| Myocardial infarction \|\| id:798 | 23 | 0.036103296 | 0.11281674 | 0.748955303 |
| Myo-inositol \|\| id:417 | 2 | 3.542010231 | 1.229214569 | 0.003957582 |
| N2,N2-dimethylguanosine \|\| id:679 | 2 | 1.532148057 | 1.040124762 | 0.140739556 |
| N-acetylglycine \|\| id:449 | 2 | -0.094001118 | 0.278219367 | 0.735463484 |
| Neuroblastoma \|\| id:816 | 3 | -0.063121558 | 0.04059461 | 0.119964025 |
| Neuroticism \|\| id:1007 | 8 | -0.226641986 | 0.295035897 | 0.442377615 |
| Octadecanedioate \|\| id:735 | 2 | 0.168223453 | 0.387875723 | 0.664503026 |
| Octanoylcarnitine \|\| id:615 | 2 | 0.239664898 | 0.195412613 | 0.220027267 |
| Omega-3 fatty acids \|\| id:855 | 5 | 0.0584919 | 0.070969856 | 0.409837574 |
| Omega-6 fatty acids \|\| id:856 | 7 | 0.345266051 | 0.223808569 | 0.1229073 |
| Omega-9 and saturated fatty acids \|\| id:857 | 4 | -0.057238543 | 0.081939934 | 0.484837865 |
| Packed cell volume \|\| id:274 | 12 | -0.045955362 | 0.035044091 | 0.189736715 |
| palmitoleic acid \(16:1n7\) \|\| id:1156 | 5 | 0.236729204 | 0.451608136 | 0.600145263 |
| Palmitoyl sphingomyelin \|\| id:751 | 2 | -0.195485353 | 1.011434541 | 0.84674334 |
| Parkinson's disease \|\| id:812 | 4 | 0.025532479 | 0.060356254 | 0.672273701 |
| PGC cross-disorder traits \|\| id:803 | 4 | 0.139057304 | 0.10788754 | 0.197429456 |
| Phospholipids in IDL \|\| id:871 | 15 | 0.152178562 | 0.148788815 | 0.306410804 |
| Phospholipids in large HDL \|\| id:879 | 7 | -0.380852872 | 0.929812152 | 0.682097965 |
| Phospholipids in large LDL \|\| id:885 | 15 | 0.180109475 | 0.143171649 | 0.208392918 |
| Phospholipids in large VLDL \|\| id:891 | 7 | 0.753017294 | 1.338664462 | 0.573765973 |
| Platelet count \|\| id:1008 | 31 | -0.000723321 | 0.000875264 | 0.408575304 |
| Primary sclerosing cholangitis  \|\| id:1112 | 14 | -0.040160471 | 0.023574575 | 0.088465159 |
| Proline \|\| id:355 | 2 | -0.698708775 | 0.377256697 | 0.064014643 |
| Propionylcarnitine \|\| id:479 | 3 | 0.459178308 | 0.840066472 | 0.584655226 |
| Putamen volume \|\| id:1047 | 4 | -7.79E-05 | 0.000187417 | 0.677523211 |
| Pyroglutamine\* \|\| id:501 | 3 | 0.210762148 | 0.270103906 | 0.435214161 |
| Ratio of bisallylic groups to double bonds \|\| id:844 | 5 | 0.025852961 | 0.051283929 | 0.614181072 |
| Ratio of bisallylic groups to total fatty acids \|\| id:845 | 5 | 0.016624257 | 0.047241572 | 0.724914083 |
| Red blood cell count \|\| id:275 | 25 | -0.071718645 | 0.229714623 | 0.754882778 |
| Rheumatoid arthritis \|\| id:831 | 7 | -0.003181378 | 0.038243408 | 0.933702348 |
| Rheumatoid arthritis \|\| id:832 | 34 | 0.007562616 | 0.023552873 | 0.748141397 |
| Rheumatoid arthritis \|\| id:833 | 43 | 0.001700282 | 0.021669376 | 0.937458361 |
| Rheumatoid arthritis \|\| id:834 | 6 | 0.014601883 | 0.027404562 | 0.594153526 |
| Schizophrenia \|\| id:22 | 68 | 0.026414399 | 0.033826454 | 0.434873117 |
| Serine \|\| id:464 | 3 | 0.154789831 | 0.520277029 | 0.766073928 |
| Serum creatinine \(eGFRcrea\) \|\| id:1104 | 37 | 0.419117345 | 0.415492064 | 0.313106408 |
| Serum creatinine \(eGFRcrea\) \|\| id:1105 | 37 | 0.440086038 | 0.377727485 | 0.243983076 |
| Serum cystatin C \(eGFRcys\) \|\| id:1106 | 5 | -0.053364467 | 0.259327728 | 0.836962743 |
| Sitting height ratio \|\| id:1070 | 4 | -0.051049201 | 0.129794887 | 0.69409296 |
| Sleep duration \|\| id:1088 | 2 | -0.134937833 | 0.391686527 | 0.730466795 |
| Stearate \(18:0\) \|\| id:331 | 2 | -1.16544658 | 0.76301855 | 0.126657653 |
| Stearic acid \(18:0\) plasma levels \|\| id:1158 | 2 | 0.039139007 | 0.067056215 | 0.559439283 |
| Succinylcarnitine \|\| id:742 | 6 | -0.588713825 | 0.51167143 | 0.249909158 |
| Systemic lupus erythematosus \|\| id:815 | 2 | -0.011411984 | 0.03647352 | 0.75436873 |
| Tetradecanedioate \|\| id:709 | 2 | 0.136930173 | 0.17823579 | 0.442336916 |
| Total cholesterol \|\| id:301 | 80 | 0.25351367 | 0.119631925 | 0.034080845 |
| Total cholesterol \|\| id:782 | 40 | 0.336262583 | 0.177520998 | 0.058196742 |
| Total cholesterol in HDL \|\| id:864 | 11 | -0.107320367 | 0.075941364 | 0.157596804 |
| Total cholesterol in IDL \|\| id:867 | 14 | 0.158478382 | 0.149402392 | 0.288804155 |
| Total cholesterol in large HDL \|\| id:874 | 11 | -0.470692798 | 0.710043707 | 0.50739025 |
| Total cholesterol in large LDL \|\| id:880 | 16 | 0.178338421 | 0.135463736 | 0.188005256 |
| Total cholesterol in large VLDL \|\| id:886 | 7 | 0.722389087 | 1.283393897 | 0.573520669 |
| Total lipids in IDL \|\| id:869 | 15 | 0.14843733 | 0.145226712 | 0.306729964 |
| Total lipids in large HDL \|\| id:877 | 7 | -0.36714531 | 0.893210655 | 0.681043202 |
| Total lipids in large LDL \|\| id:883 | 17 | 0.183697128 | 0.129062069 | 0.15464228 |
| Total lipids in large VLDL \|\| id:889 | 7 | 1.000470501 | 1.288588737 | 0.43750817 |
| Transferrin \|\| id:1052 | 7 | 0.010485392 | 0.031530259 | 0.739473885 |
| Transferrin Saturation \|\| id:1051 | 3 | -0.025070048 | 0.045155118 | 0.578758976 |
| Triglycerides \|\| id:302 | 52 | 0.209699313 | 0.150283432 | 0.162907661 |
| Triglycerides \|\| id:783 | 26 | 0.155410212 | 0.216837834 | 0.473552007 |
| Triglycerides in IDL \|\| id:872 | 13 | 0.253977805 | 0.299305828 | 0.396128308 |
| Triglycerides in large VLDL \|\| id:892 | 7 | 0.720272362 | 1.320239713 | 0.585367185 |
| Tryptophan \|\| id:304 | 17 | 0.139390245 | 0.962710509 | 0.884877178 |
| Type 2 diabetes \|\| id:23 | 25 | 0.043398668 | 0.049519566 | 0.380815685 |
| Type 2 diabetes \|\| id:24 | 35 | 0.024565978 | 0.036101688 | 0.49620932 |
| Type 2 diabetes \|\| id:25 | 19 | 0.043105872 | 0.052948929 | 0.41558605 |
| Type 2 diabetes \|\| id:26 | 10 | 0.026947366 | 0.054808886 | 0.622959343 |
| Tyrosine \|\| id:325 | 3 | -0.865204389 | 1.564044647 | 0.580137459 |
| Ulcerative colitis \|\| id:32 | 33 | 0.031893663 | 0.026949332 | 0.236623849 |
| Urate \|\| id:1055 | 24 | 0.087826794 | 0.037518233 | 0.01923682 |
| Urate \|\| id:789 | 3 | 0.022462689 | 0.033640777 | 0.504311037 |
| Urate \|\| id:792 | 3 | 0.004224752 | 0.013770388 | 0.758995762 |
| Urate \|\| id:795 | 4 | 0.097363145 | 0.054798529 | 0.075609809 |
| Uridine \|\| id:316 | 3 | -0.559673039 | 1.057987687 | 0.596807055 |
| Waist circumference \|\| id:60 | 44 | -0.054430702 | 0.129070715 | 0.673235061 |
| Waist circumference \|\| id:61 | 39 | -0.052397904 | 0.146339593 | 0.720300717 |
| Waist circumference \|\| id:66 | 59 | -0.119298395 | 0.098700642 | 0.22678229 |
| Waist circumference \|\| id:67 | 60 | -0.040907262 | 0.102107599 | 0.688693313 |
| Waist-to-hip ratio \|\| id:72 | 29 | -0.170082114 | 0.137250112 | 0.215266652 |
| Waist-to-hip ratio \|\| id:73 | 28 | -0.033598321 | 0.147237363 | 0.819497334 |
| Waist-to-hip ratio \|\| id:78 | 35 | 0.060154668 | 0.111547726 | 0.589698549 |
| Waist-to-hip ratio \|\| id:79 | 35 | 0.116554774 | 0.118247072 | 0.324286016 |
| X-02269 \|\| id:485 | 2 | 0.022496373 | 0.253843118 | 0.92938142 |
| X-03094 \|\| id:373 | 3 | -1.040881181 | 0.703048963 | 0.13873334 |
| X-08402 \|\| id:426 | 2 | 0.307928297 | 0.291290227 | 0.290457495 |
| X-08988 \|\| id:435 | 2 | -0.619066325 | 0.544735223 | 0.255766759 |
| X-10510 \|\| id:444 | 3 | 0.439663233 | 0.419461112 | 0.294563936 |
| X-11204 \|\| id:484 | 2 | -1.826738144 | 1.214275857 | 0.132482315 |
| X-11315 \|\| id:495 | 3 | 0.217245528 | 0.451492224 | 0.630394083 |
| X-11327 \|\| id:498 | 2 | 1.697183707 | 1.188802165 | 0.153394975 |
| X-11423--O-sulfo-L-tyrosine \|\| id:509 | 2 | -0.332182349 | 0.809982315 | 0.681724803 |
| X-11440 \|\| id:513 | 3 | -0.015945617 | 0.224484203 | 0.943372092 |
| X-11445--5-alpha-pregnan-3beta,20alpha-disulfate \|\| id:517 | 4 | 0.045862801 | 0.15505864 | 0.767400282 |
| X-11469 \|\| id:519 | 3 | -0.171219544 | 0.224505507 | 0.445671044 |
| X-11491 \|\| id:524 | 3 | 0.070633025 | 0.248221776 | 0.775984233 |
| X-11529 \|\| id:528 | 2 | -0.00109141 | 0.157065113 | 0.994455725 |
| X-11538 \|\| id:531 | 3 | 0.138831256 | 0.159427615 | 0.38385758 |
| X-11593--O-methylascorbate\* \|\| id:536 | 6 | 0.106007842 | 0.291606527 | 0.716208698 |
| X-11787 \|\| id:541 | 2 | -0.517681454 | 0.387882766 | 0.181996226 |
| X-11792 \|\| id:542 | 3 | -0.095035976 | 0.107703718 | 0.377569496 |
| X-11793--oxidized bilirubin\* \|\| id:543 | 2 | 0.079422566 | 0.173400989 | 0.646932083 |
| X-11905 \|\| id:560 | 2 | 0.00629833 | 0.397345672 | 0.987353255 |
| X-12063 \|\| id:570 | 7 | -0.105158287 | 0.177974564 | 0.554613341 |
| X-12092 \|\| id:580 | 4 | -0.02590546 | 0.099003686 | 0.793582372 |
| X-12188 \|\| id:587 | 2 | 0.005835489 | 0.097407865 | 0.952229084 |
| X-12189 \|\| id:588 | 2 | 0.033535285 | 0.082322107 | 0.683738679 |
| X-12244--N-acetylcarnosine \|\| id:596 | 3 | -0.097139276 | 0.60524573 | 0.872490688 |
| X-12456 \|\| id:613 | 2 | 0.063654998 | 0.239030294 | 0.790004207 |
| X-12510--2-aminooctanoic acid \|\| id:629 | 3 | -0.203276419 | 0.170260468 | 0.232511469 |
| X-12524 \|\| id:630 | 2 | 0.294618517 | 1.403402369 | 0.833721052 |
| X-12556 \|\| id:633 | 2 | -0.224452434 | 0.610424061 | 0.713097543 |
| X-12644 \|\| id:636 | 3 | -0.474089902 | 0.966930772 | 0.623918887 |
| X-12696 \|\| id:640 | 2 | -0.772918114 | 0.506221646 | 0.126801463 |
| X-12728 \|\| id:646 | 4 | 0.001165733 | 0.04049965 | 0.977037032 |
| X-12798 \|\| id:661 | 3 | -0.113570533 | 0.130921422 | 0.38568401 |
| X-12844 \|\| id:665 | 3 | -0.288909275 | 0.710912607 | 0.684454516 |
| X-12850 \|\| id:667 | 2 | -0.462343569 | 0.333204269 | 0.165268643 |
| X-12855 \|\| id:670 | 2 | -0.348891533 | 0.477289502 | 0.464788231 |
| X-13215 \|\| id:675 | 2 | 0.923389555 | 0.931416162 | 0.321498909 |
| X-13429 \|\| id:683 | 3 | 0.135998575 | 0.127093408 | 0.28458875 |
| X-13431--nonanoylcarnitine\* \|\| id:684 | 2 | -0.309685484 | 0.181106554 | 0.087272739 |
| X-13435 \|\| id:685 | 2 | 0.027492233 | 0.421590243 | 0.94800617 |
| X-13496 \|\| id:691 | 2 | -0.665297503 | 1.289019209 | 0.605765773 |
| X-13548 \|\| id:693 | 2 | -0.592837833 | 1.135131158 | 0.601486719 |
| X-14189--leucylalanine \|\| id:719 | 2 | -0.544929003 | 0.372655498 | 0.143662791 |
| X-14208--phenylalanylserine \|\| id:721 | 2 | -0.516874007 | 0.220875188 | 0.019277647 |
| X-14304--leucylalanine \|\| id:722 | 2 | -0.578222895 | 0.424988213 | 0.173652087 |
| X-14626 \|\| id:729 | 2 | 0.422033958 | 0.364483832 | 0.246906943 |
| X-18601 \|\| id:396 | 2 | -0.63499551 | 0.45540555 | 0.16321142 |
| Years of schooling \|\| id:1001 | 64 | -0.529487966 | 0.139348812 | 0.000144853 |
| Years of schooling \|\| id:755 | 4 | -0.493246474 | 0.314660974 | 0.116986438 |
| Years of schooling \|\| id:837 | 4 | -0.332106736 | 0.477554358 | 0.48678441 |
| Zinc \|\| id:1079 | 2 | -0.014035699 | 0.075691812 | 0.85289006 |

